RANDOMISED DOUBLE BLIND STUDY TO COMPARE EFFECTIVENESS OF HONEY, SALBUTAMOL AND PLACEBO IN TREATMENT OF COUGH IN CHILDREN WITH COMMON COLD by Waris, Adil et al.
eCommons@AKU
Paediatrics and Child Health, East Africa Medical College, East Africa
January 2014
RANDOMISED DOUBLE BLIND STUDY TO
COMPARE EFFECTIVENESS OF HONEY,
SALBUTAMOL AND PLACEBO IN
TREATMENT OF COUGH IN CHILDREN
WITH COMMON COLD
Adil Waris
Aga Khan University, adil.waris@aku.edu
William Macharia
Aga Khan University, william.macharia@aku.edu
E. K. Njeru
University of Nairobi
F. Essajee
Aga Khan University
Follow this and additional works at: https://ecommons.aku.edu/
eastafrica_fhs_mc_paediatr_child_health
Part of the Pediatrics Commons
Recommended Citation
Waris, A., Macharia, W., Njeru, E. K., Essajee, F. (2014). RANDOMISED DOUBLE BLIND STUDY TO COMPARE
EFFECTIVENESS OF HONEY, SALBUTAMOL AND PLACEBO IN TREATMENT OF COUGH IN CHILDREN WITH
COMMON COLD. East African Medical Journal, 91(2), 50-56.
Available at: https://ecommons.aku.edu/eastafrica_fhs_mc_paediatr_child_health/146
50 East african MEdical Journal February 2014 
East African Medical Journal Vol. 91 No. 2 February 2014
RANDOMISED DOUBLE BLIND STUDY TO COMPARE EFFECTIVENESS OF HONEY, SALBUTAMOL AND PLACEBO 
IN TREATMENT OF COUGH IN CHILDREN WITH COMMON COLD
A. Waris, MBChB, MMed, W. M. Macharia MBChB, MMed, MSc, Departments of Paediatrics, Aga Khan University Hospital, 
P. O. Box 30270-00100, Nairobi, E. K. Njeru, BSc, MSc, School of Public Health and Clinical Epidemiology Unit, University of 
Nairobi, P. O. Box 19676-00202 and F. Essajee, MBChB, MMEd, Departments of Paediatrics, Aga Khan University Hospital, 
P. O. Box 30270-00100, Nairobi, Kenya
RANDOMISED DOUBLE BLIND STUDY TO COMPARE EFFECTIVENESS 
OF HONEY, SALBUTAMOL AND PLACEBO IN TREATMENT OF COUGH IN 
CHILDREN WITH COMMON COLD
A. WARIS, W. M. MACHARIA, E. K. NJERU and F. ESSAJEE
ABSTRACT
Background: Acute upper respiratory infection is the most common childhood illness 
and presents with cough, coryza and fever.  Available evidence suggests that cough 
medicines may be no more effective than honey-based cough remedies. 
Objective: To compare effectiveness of honey, salbutamol and placebo in the treatment 
of cough in children with acute onset cough.
Design: Randomised control trial 
Setting: Aga Khan University Hospital Paediatric Casualty
Subjects: Children between ages one to twelve years presenting with a common cold 
between December 2010 and February 2012 were enrolled.
Outcome measures: Frequency, severity and extent to which cough bothered and 
disturbed child and parental sleep were assessed at baseline and over the subsequent 
five days through telephone interview using a validated scoring tool.
Results: One hundred and forty five children were enrolled in the study (45- placebo, 
57 –honey, 43 –salbutamol).  Of the 145 children 51% were male.  Honey significantly 
reduced the total mean symptom score by day three (p< 0.001).  Total mean difference 
in scores between day zero to five demonstrated a significant difference of honey’s 
efficacy over placebo (p< 0.002) however no difference was noted when compared to 
salbutamol (p<0.478).  Significant differences in both total as well as each individual 
symptom score was detected with honey consistently scoring the best whilst placebo 
and salbutamol scored the worst.  In paired comparisons honey was superior to placebo 
but not salbutamol, whilst salbutamol was not superior to placebo.
Conclusion:  Honey was most effective in symptomatic relief of symptoms associated 
with the common cold whilst salbutamol or placebo offered no benefit.
INTRODUCTION
Common cold is a viral infection affecting the upper 
airways and is defined by the presence of rhinorrhea 
and cough for about five days’ duration. Other 
symptoms may include acute nasal congestion, fever, 
sore throat, myalgia and headache.  Common cold 
contributes to significant childhood morbidity, sleep 
disturbance in child and family members, loss of 
school days for the older child, parental anxiety and 
low productivity.  Cough mixtures are among the most 
commonly prescribed medications for coughs and 
colds in adults and children (1, 2). Cough mixtures 
may have one or more of various medicaments; anti-
tussives, anti-histamines, expectorants, decongestants 
or mucolytics.  Recent systematic reviews from the 
Cochrane database and recommendations from the 
American College of Chest Physicians and the World 
Health Organisation (WHO) suggest a lack of efficacy 
of most cough mixture ingredients whether used 
singly or in combination.(3, 4).
 Recently there have been blinded trials 
suggesting benefit from use of natural demulcents 
such as honey, for the treatment of the common cold 
(5).  It has also been recommended as a soothing agent 
for cough in children by the WHO (3).  Additionally, 
honey has anti-oxidant properties and increases 
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cytokine release, which may explain its anti-microbial 
effects and apparent benefit in both common cold and 
during skin wound healing (4,7,8). Honey is readily 
available, affordable and culturally acceptable to most 
parents.  However, there has been caution drawn to 
possible infantile botulism associated with use of 
honey in infants, especially before the age of one year 
(10-13). There has not been any such reports from 
Africa suggesting that African honey may be safe to 
use in children under 12 months of age and unlike 
cough mixtures is not associate with any important 
adverse effects (5). Paul and colleagues (5) note that 
darker honeys, such as the buckwheat variety, consist 
of more phenolic compounds than other varieties 
and that the associated anti-oxidant effect might 
have contributed to the improvement seen in those 
children treated with this kind of honey. 
 Salbutamol is a common ingredient of cough 
mixtures and is often prescribed singly or in 
combination mixtures for children with the common 
cold despite formal evaluation of its efficacy. 
Justification for its use is based on its ability to induce 
mucociliary clearance of lower airways by increasing 
frequency of cilia beat hence faster expectoration (6). 
It is also a potent bronchodilator which theoretically 
should allow easy expectoration of mucus and 
thus a quicker relief of cough symptoms.  Some of 
the side effects of salbutamol include tachycardia, 
palpitations, headache and tremor. 
MATERIALS AND METHODS
We conducted a hospital based randomised double-
blinded clinical trial evaluating effectiveness of 
honey and salbutamol against that of placebo at 
the paediatric casualty of the Aga Khan University 
Hospital Nairobi.  This is a national tertiary referral 
and teaching hospital serving the middle/upper-
income society in Nairobi and its environs.  The 
study was approved by the Aga Khan University 
hospital ethics and research committee.  Study 
patients were recruited from December 2010 through 
to February 2012.  The study population included 
children aged between one and twelve years with 
an uncomplicated acute upper respiratory infection. 
Exclusion criteria included prior use (48 hours) of any 
cough mixture, study agents, oral anti-histamines, 
nasal decongestants, steroids or anti-biotics.  Other 
exclusions were any past history of atopy, asthma or 
any chronic lung disease as well as hospitalisation for 
lower respiratory tract infection in the past six months. 
 Cough is a difficult symptom to quantify and 
investigators have struggled with identification 
of an appropriate outcome measurement for trials 
on cough treatment, therefore the Likert scale was 
used as its one amongst a few validated tools of 
assessing severity of cough in children and has the 
benefit of incorporating both child and parental 
sleep disturbance as a surrogate for severity of cough 
intensity (9). 
 The Likert scale comprised of five questions, each 
having a score from 0 – 6 ranging from “not at all” 
to “extremely”.  The five questions inquired about 
the frequency, severity, how bothersome the cough 
was, how it affected the child’s and the parents’ sleep. 
Likert scale used is shown in Figure 1 below.
Figure 1
Likert cough assessment severity score
1. How frequent was your child’s coughing 
yesterday?
2. How severe was your child’s cough yesterday?
3. How bothersome was last night’s cough to your 
child?
4. How much did last night’s cough affect your 
child’s ability to sleep?
5. How much did last night’s cough affect your 
PARENTS ability to sleep?
6 Extremely _ 5 Very much _ 4 A lot _ 3 Somewhat _ 
2 A little _ 1 Not Much _O Not at all
Informed written consent from the parent/guardian 
was taken at the casualty where for those who 
answered at least somewhat (3 points) for a minimum 
of two of the three questions related to nocturnal 
cough frequency, effect on the child’s sleep, and 
effect on parental sleep based on the previous night’s 
symptoms at initial assessment.  Dispensing of the 
study drugs was undertaken following a random 
order previously generated by a statistician not 
involved in care of study patients.  All three study 
drugs were prepared, bottled, packaged and labeled 
as Study Drug A, B and C by Universal Corporation 
Ltd (P.O Box: 1748-00902), based in Kikuyu who 
also held the code until after statistical analysis was 
completed.  The dose prescribed for all the three study 
agents was 2.5 ml (age one to two years), 5 ml (age 
2-6 years) and 7.5 ml (age six to twelve years) and all 
were administered thrice daily for five days.  Syrup 
salbutamol has 2 mg of active ingredient per 5ml. 
The darkest locally available honey was used.  Placebo 
was a brown colored sugar and alcohol free syrup 
with an inert thickening agent whose ingredients 
included sodium citrate, citric acid monohydrate, 
hypromellose, sodium benzoate, saccharin sodium, 
sodium chloride, caramel colour and water.  Parents 
were then contacted by telephone daily for five days 
and the Likert scale questionnaire administered 
repeatedly. 
 Adherence to medications was confirmed at 
each telephonic interview as well as any possible 
side effects.  Patients requiring further evaluations 
by doctors and those for whom anti-biotics were 
prescribed were excluded from final analysis. 
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Sample size: To compare that average response for three 
groups over six days with repeated measurements 
across the three groups made from baseline to day 
five, the following formula for sample size per group 
is used (17).
n = 2o
2(1 + (m – 1)p)∗(za/2+ zβ)2
d2
Sample size was calculated with the aim to detect a 
1-point difference between any two treatment groups 
using 0.05 significance with 90% power, giving 37 
subjects per group.
 Two main outcome variables were considered 
in this study; the duration in days from initiation 
of treatment till the scores reduced to zero and the 
difference in scores between day- 5 and day -0.  In 
statistical analyses, a generalised linear model was 
used to compare the mean treatment group scores 
given the repeated measurements on the cough scores. 
Tukey’s Honestly Significant Difference was used in 
post-hoc test to carry out pair-wise comparisons of 
the groups. 
RESULTS 
The study enrolled 145 children with acute onset 
cough but complete data were available for 133 
(91.7%).  Forty five children received placebo, 57 
received honey whilst 43 received salbutamol. Of 
those randomised to receive placebo, honey and 
salbutamol, those who were lost to follow up or 
refused to adhere with medications were six, four 
and two study participants respectively for the three 
groups.  Fifty-one percent of all participants were 
male.  Table 1 below shows the baseline characteristics 
of the components of the Likert scale across the three 
groups.
Table 1
Baseline characteristics of the three study groups
Baseline characteristics Receiving 
Placebo (N = 45)
Receiving 
Honey  
(N = 57)
Receiving 
Salbutamol  
(N = 43)
P-Value
Female No. (%) 21 (50.0%) 24 (44.4%) 22 (53.7%) 0.663
Male No. (%) 21 (50.0%) 30 (55.6%) 19 (46.3%)
Cough frequency score, mean ±SD 3.05 ± 0.76 3.27 ± 0.75 3.09 ± 0.84 0.32
Cough severity score, mean ±SD     2.81 ± 1.06 3.04 ± 1.07 2.91 ± 1.04 0.57
Cough bothersome score, mean ±SD 2.52 ± 1.19 2.91 ± 1.07 2.93 ± 1.20 0.18
Cough effect on child sleep score, mean 
±SD   
2.31 ± 1.63 2.40 ± 1.21                              2.86 ± 1.45 0.15
Cough effect on parent sleep score, 
mean ±SD
2.19 ± 1.02 2.36 ± 1.00                              2.77 ± 1.08 0.19
Combined symptom score, mean±SD  12.88±5.31 13.98±4.51 14.56±5.09  0.29
There were no significant differences between both total and individual measures of symptom severity at 
baseline.  The total mean score for children on first day of enrollment was 12.88, 13.98 and 14.56 for placebo, 
honey and salbutamol respectively (p = 0.29). 
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Figure 1
Total mean Likert scores (A – placebo, B – honey, C – salbutamol) 
By day three honey had significantly reduced the total 
mean symptom score (p = 0.001) and this significance 
over both salbutamol and placebo was again noted 
on days four and five.
 The total mean difference in scores between day 
5 and day 0 were 8.69, 12.68 and 11.37 for placebo, 
honey and salbutamol respectively. Honey again 
demonstrated superior effectiveness in reducing 
overall symptom score (p = 0.003).
 A general linear model with cough scores 
measured over the six day period indicated a 
statistically significant difference between honey, 
salbutamol and placebo (p = 0.000).  Paired analysis 
of the total mean difference in scores between day 
5 and day 0 demonstrated efficacy of honey over 
placebo (p = 0.002) but when compared to salbutamol, 
there was no statistically significant difference noted 
(p = 0.478).  Effect of salbutamol was not different 
from that of placebo (p = 0.075).
Figure 2
Time interval to clearance of the cough (A – placebo, B – honey, C – salbutamol)
 
The mean time interval to clearance of cough in days was 5.18, 4.46, 5.0 for placebo, honey and salbutamol 
respectively using ANOVA (p = 0.019), indicating that those on honey were first to get complete relief of 
their symptoms.  This was reconfirmed in paired analysis of mean time interval to clearance of cough score 
showing honey superiority over placebo (p = 0.023).  However difference in response between honey and 
salbutamol was not statistically different (p = 0.11).  Effect of salbutamol was comparable to that of placebo 
(p = 0.81).
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Figure 3
Assessment of individual parameters of the Likert score versus the three study drugs (A – Placebo, B – honey, C – 
salbutamol) 
  
When each individual parameter was evaluated honey scored consistently better than either placebo or 
salbutamol with significant differences noted again on day three for each individual variable which included 
frequency of cough (p = 0.003), severity of cough (p = 0.03), how bothersome was last night’s cough to your 
child (p = 0.038), effect of last night’s cough on child’s ability to sleep (p = 0.001) and how much did last 
night’s cough affect the parents ability to sleep (p = 0.006).
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Table 2
Side effects profile of the study drugs 
Side Effects Reported Placebo 
Count (percent)
Honey 
Count (Percent)
Salbutamol 
Count (percent)
Nausea 3 (1.4) 8 (2.9) 0  (0)
Abdominal pain 1 (0.5) 7 (2.5) 3 (1.4)
Diarrhea 6 (2.9) 7 (2.5) 9 (4.3)
Vomiting 8 (3.8) 15 (5.4) 10 (4.8)
Hand tremor 0 (0) 0 (0) 0 (0)
Rash 0 (0) 1 (0.4) 4 (1.9)
Tachycardia 1 (0.5) 2 (0.7) 1 (0.5)
Others 5 (2.4) 4 (1.4) 3 (14)
Children administered honey had more reports 
of gastrointestinal complaints but none were 
significantly more than that of either placebo or 
salbutamol group.      
 The rest of the side effect profile was minimal 
with none of the study drugs showing significant 
differences over that of placebo. 
DISCUSSION 
In this study, honey performed better in clearance of 
cough symptoms over either placebo or salbutamol 
using the Likert score as a tool of validation.  Studies 
by both Paul in 2007 and Cohen in 2012 comparing 
just honey to placebo over single day duration showed 
similar results (5, 16).  
 This study we believe is the first fully blinded 
randomised placebo controlled trial evaluating 
effectiveness of honey over a five day duration of 
the common cold during which honey continued to 
show significant difference over placebo.
 The putative mechanism of action of honey as a 
soother of cough ranges from its possible antioxidant 
activity, demulcent and or natural antiseptic/
antibiotic properties (4,7,8). Substitution of cough 
mixtures with honey will translate into major cost 
savings, a 300 ml bottle of honey costs US$ 4- 6 
locally and would be enough to treat four children 
thus reducing the real cost per child to approximately 
one US dollar whereas a standard cough mixture or 
syrup salbutamol will retail at five dollars per bottle 
hence five times the cost.  Its benefit over salbutamol 
continues to emphasise the need to curtail the 
widespread abuse of cough mixture prescriptions 
worldwide.  It positively lends weight to the WHO 
directive on the role of demulcents for the common 
cold (3). 
 Although not significant there were more 
gastrointestinal side effects with honey over either 
placebo or salbutamol.
This study showed no benefit of salbutamol over 
either placebo or honey.  It was hypothesised that 
it may have helped with nocturnal cough and 
thus effect of sleep but this was not significant 
when analysed.  Salbutamol and other short acting 
bronchodilators are used as a common ingredient for 
many cough mixtures both in Kenya and worldwide 
which led us to justify its inclusion as one of our 
study agents.  Placebo controlled randomised trials 
comparing the effectiveness of antihistamines and 
dextromethorphan have been conducted by Paul et 
al (5) confirming that these individual agents have no 
effect on cough symptoms of the common cold but 
we have as yet to find similar trials using salbutamol 
in the same manner. There was no noted increase 
of hand tremor and tachycardia in the study group 
using salbutamol as against placebo in this study.        
 One drawback encountered during this study 
was the large number of patients who could not be 
initially recruited as they had taken one of the study 
drugs, cough mixture or antihistamines prior to 
presentation to seek further treatment. 
In conclusion, honey has consistently showed benefit 
for the cough symptom during the common cold 
and this study offers reason to continue to advocate 
for its use as a cheaper, safer and easily available 
cough mixture.  Salbutamol for the common cold 
symptoms has not been shown to be useful and hence 
its prescription should be avoided.
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